Aerie Pharmaceuticals, Inc. (AERI) financial statements (2021 and earlier)

Company profile

Business Address 4301 EMPEROR BOULEVARD
DURHAM, NC 27703
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments240309203250234137140
Cash and cash equivalents1521442031981989186
Short-term investments89165 52364654
Receivables56383    
Inventory, net of allowances, customer advances and progress billings272110    
Inventory272110    
Other undisclosed current assets8854421
Total current assets:332376220254238138141
Noncurrent Assets
Operating lease, right-of-use asset1417
Property, plant and equipment54586132840
Long-term investments and receivables     1418
Long-term investments     1418
Other noncurrent assets2244332
Total noncurrent assets:70766536112120
TOTAL ASSETS:402453285290248159161
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1007851231055
Accounts payable913126622
Accrued liabilities9165389   
Employee-related liabilities   8432
Interest and dividends payable    111
Debt 6     
Other undisclosed current liabilities5  29124
Total current liabilities:10484512519179
Noncurrent Liabilities
Long-term debt and lease obligation221201 124124123124
Long-term debt, excluding current maturities210189 124124123124
Operating lease, liability1012
Liabilities, other than long-term debt53166   
Deferred revenue51 
Other liabilities2166   
Total noncurrent liabilities:2742026129124123124
Total liabilities:37828657155143140133
Stockholders' equity
Stockholders' equity attributable to parent241672281361051928
Common stock0000000
Additional paid in capital1,1031,063924597422236171
Accumulated other comprehensive loss(0)(0) (0)(0)(0)(0)
Accumulated deficit(1,079)(896)(696)(462)(317)(218)(143)
Total stockholders' equity:241672281361051928
TOTAL LIABILITIES AND EQUITY:402453285290248159161

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues837024    
Cost of revenue(28)(28)(27)    
Cost of goods and services sold(25)(23)(1)    
Other cost of operating revenue (5)     
Gross profit:5642(3)    
Operating expenses(211)(230)(207)(146)(97)(75)(50)
Operating loss:(156)(187)(210)(146)(97)(75)(50)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(22)(12)(23)(1)(2)12
Interest and debt expense(27)(15) (0)(3)(2)(1)
Loss from continuing operations before equity method investments, income taxes:(204)(215)(233)(147)(101)(77)(49)
Other undisclosed income from continuing operations before income taxes2715 032 
Loss from continuing operations before income taxes:(178)(200)(233)(147)(99)(74)(49)
Income tax expense (benefit)(5)0(0)2(0)(0) 
Net loss:(183)(200)(233)(145)(99)(74)(49)
Other undisclosed net income attributable to parent      1
Net loss available to common stockholders, diluted:(183)(200)(233)(145)(99)(74)(48)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(183)(200)(233)(145)(99)(74)(49)
Other comprehensive loss    (99)(74)(48)
Comprehensive loss:(183)(200)(233)(145)(198)(149)(97)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0(0)00   
Comprehensive loss, net of tax, attributable to parent:(183)(200)(233)(145)(198)(149)(97)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: